Studies suggest that surface-expressed Igs from cancer cells (cIgGs) may have the opposite effect to B lymphocyte-produced IgGs, and may instead be essential for cancer growth by interacting with serum components that are harmful to cancer cells [25]. This evidence concerns the gene CUBN and cancer.